Mastering Melanoma: MRF Virtual Patient Symposia 2023

Dr.Rebecca Hartman is Associate Chief of the Dermatology section at VA BostonHealthcare System, Director of Melanoma Epidemiology at Brigham and Women’sHospital, and Assistant Professor of Dermatology at Harvard Medical School. Sheclinically specializes in caring for patients with melanoma and pigmentedlesions at Dana Farber Cancer Institute and practices medical dermatology at VABoston. In addition, she conducts melanoma epidemiologic and clinical researchfunded by the VA and Department of Defense, focusing on aggressive and raremelanomas.

Dr. Tara Mitchell is an Associate Professor of medicine at the University of Pennsylvania’s Perelman School of Medicine. She is the Section Chief of melanoma/sarcoma in the division of Hematology/Oncology at Penn's Abramson Cancer Center and the Director of Clinical Research for the Tara Miller Melanoma Center at Penn. Dr. Mitchell is board certified in both medical oncology and clinical pharmacology.

Dr. Sondak is Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He holds the Richard M. Schulze Family Foundation Distinguished Endowed Chair in Cutaneous Oncology, and is also a Professor in the Departments of Oncologic Sciences and Surgery at the University of South Florida Morsani College of Medicine. Since 2004, when he came to Tampa, the Cutaneous Oncology Clinic at Moffitt has grown into one of the largest multidisciplinary treatment centers for pediatric melanoma and related conditions in the world. Dr. Sondak has been a leader in studies of surgical treatment of melanoma and other cutaneous malignancies, particularly in the application of sentinel lymph node biopsy and lymph node dissection to the staging and treatment of melanoma, and has been instrumental in training many surgical oncologists in these techniques over the years. Dr. Sondak also has a strong research background: he served as Principal Investigator of the Moffitt Skin SPORE, a major NCI-funded “team science” grant conducting translational research in melanoma and other cutaneous malignancies. His research interests include surgical treatment of melanoma in adults and children; adjuvant (postoperative) and neoadjuvant (preoperative) therapy of melanoma; and evaluation of new therapies for patients with localized or disseminated melanoma.

Dr. Wuthrick is an Associate Member in radiation oncology at Moffitt Cancer Center and the Section Head for Cutaneous Radiation Oncology with clinical and research interests centered around cutaneous malignancies.  Dr. Wuthrick is the clinical director of radiation oncology at Moffitt Cancer, associate chair of Graduate Medical Education at Moffitt, and Chair of the NRG Oncology Radiation Oncology Committee.